Cancer‐related mortality at maximal · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to recurrence · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Daytime sleepiness (ESS): endpoint score. · obstructive sleep apnoea
1 finding from 1 review
Daytime sleepiness (ESS): endpoint score. · obstructive sleep apnoea
1 finding from 1 review
AHI · obstructive sleep apnoea
1 finding from 1 review
Snoring frequency: endpoint score. · obstructive sleep apnoea
1 finding from 1 review
Snoring intensity: endpoint score. · obstructive sleep apnoea
1 finding from 1 review
Quality of sleep · obstructive sleep apnoea
1 finding from 1 review
Reduction of apnoea episodes (apnoea-hypopnoea index) · obstructive sleep apnoea
1 finding from 1 review
Snoring frequency: change from baseline. · obstructive sleep apnoea
1 finding from 1 review
Snoring intensity: endpoint score. · obstructive sleep apnoea
1 finding from 1 review
All‐cause mortality Up to 28 days following admission · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number of deaths at 30 days following admission (30‐day mortality)a compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of admissions to the ICU · individuals with influenza
It is very uncertain whether corticosteroid therapy changes rate of admission to intensive care units compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Number and nature of adverse events secondary to corticosteroid use (hospital‐acquired infection) · individuals with influenza
It is very uncertain whether corticosteroid therapy changes number and nature of adverse events secondary to corticosteroid use… compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Incidence of mechanical ventilation · individuals with influenza
It is very uncertain whether corticosteroid therapy changes proportion of participants requiring mechanical ventilation compared with no corticosteroid therapy (very low certainty).
1 finding from 1 review
Mortality (respiratory‐ related and all‐cause · adults with acute exacerbations of chronic obstructive pulmonary disease
Titrated oxygen therapy may leads to lower mortality (respiratory‐ related and all‐cause compared with high‐flow oxygen therapy (low certainty).
1 finding from 1 review
Arterial blood gas (pH) · adults with acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review
Ventilation of any type · adults with acute exacerbations of chronic obstructive pulmonary disease
Titrated oxygen therapy showed no clear difference in ventilation of any type compared with high‐flow oxygen therapy (low certainty).
1 finding from 1 review
Length of hospital stay · adults with acute exacerbations of chronic obstructive pulmonary disease
1 finding from 1 review